Corrigendum: Efficient in vitro generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell niche

Frontiers in Immunology

Immunology

Roland Meisel¹  Özer Degistirici¹  Markus Uhrberg²  Sabrina B. Bennstein²  Sandra Weinhold²  Gesine Kögler²  Katharina Raba²  Lutz Walter³  Robert A. J. Oostendorp⁴ 

[1] Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Children and Adolescence Health, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany;Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany;Primate Genetics Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany;Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Internal Medicine III – Hematology and Oncology, Laboratory of Stem Cell Physiology, Munich, Germany;

关键词: CD34 cells;    mesenchymal stem cells;    umbilical cord stem cells (UCSC);    innate lymphoid cells (ILCs);    ILC3;    hematopoietic stem and progenitor cells;    GMP—Good Manufacturing Practice;   

DOI  :  10.3389/fimmu.2023.1292209

 received in 2023-09-11, accepted in 2023-09-12,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Bennstein, Weinhold, Degistirici, Oostendorp, Raba, Kögler, Meisel, Walter and Uhrberg